152 related articles for article (PubMed ID: 11554731)
1. Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts.
Ohnaka K; Shimoda S; Nawata H; Shimokawa H; Kaibuchi K; Iwamoto Y; Takayanagi R
Biochem Biophys Res Commun; 2001 Sep; 287(2):337-42. PubMed ID: 11554731
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
3. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells.
Maeda T; Matsunuma A; Kurahashi I; Yanagawa T; Yoshida H; Horiuchi N
J Cell Biochem; 2004 Jun; 92(3):458-71. PubMed ID: 15156558
[TBL] [Abstract][Full Text] [Related]
4. Effect of pitavastatin on apolipoprotein A-I production in HepG2 cell.
Maejima T; Yamazaki H; Aoki T; Tamaki T; Sato F; Kitahara M; Saito Y
Biochem Biophys Res Commun; 2004 Nov; 324(2):835-9. PubMed ID: 15474503
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG-63 cultures.
Ruiz-Gaspa S; Nogues X; Enjuanes A; Monllau JC; Blanch J; Carreras R; Mellibovsky L; Grinberg D; Balcells S; Díez-Perez A; Pedro-Botet J
J Cell Biochem; 2007 Aug; 101(6):1430-8. PubMed ID: 17252541
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone upregulates BMP-2 mRNA expression through mevalonate kinase and Rho kinase inhibition in osteoblastic MC3T3-E1 cells.
Takase H; Yano S; Yamaguchi T; Kanazawa I; Hayashi K; Yamamoto M; Yamauchi M; Sugimoto T
Horm Metab Res; 2009 Dec; 41(12):861-5. PubMed ID: 19672814
[TBL] [Abstract][Full Text] [Related]
7. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of Cbfa1/Runx2 and osteocalcin gene expression by vitamin-D3, dexamethasone, and local growth factors in primary human osteoblasts.
Viereck V; Siggelkow H; Tauber S; Raddatz D; Schutze N; Hüfner M
J Cell Biochem; 2002; 86(2):348-56. PubMed ID: 12112004
[TBL] [Abstract][Full Text] [Related]
9. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
Kuo PL; Hsu YL; Chang CH; Chang JK
J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells.
Kim DJ; Moon SH; Kim H; Kwon UH; Park MS; Han KJ; Hahn SB; Lee HM
Spine (Phila Pa 1976); 2003 Dec; 28(24):2679-84. PubMed ID: 14673369
[TBL] [Abstract][Full Text] [Related]
11. [Statin and BMP].
Ohnaka K; Takayanagi R
Clin Calcium; 2004 Feb; 14(2):286-8. PubMed ID: 15576985
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the mevalonate pathway rescues the dexamethasone-induced suppression of the mineralization in osteoblasts via enhancing bone morphogenetic protein-2 signal.
Kanazawa I; Yamaguchi T; Yano S; Hayashi K; Yamauchi M; Sugimoto T
Horm Metab Res; 2009 Aug; 41(8):612-6. PubMed ID: 19384817
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
15. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells.
Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW
Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111
[TBL] [Abstract][Full Text] [Related]
16. Statin suppresses apoptosis in osteoblastic cells: role of transforming growth factor-beta-Smad3 pathway.
Kaji H; Naito J; Inoue Y; Sowa H; Sugimoto T; Chihara K
Horm Metab Res; 2008 Nov; 40(11):746-51. PubMed ID: 18622892
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
[TBL] [Abstract][Full Text] [Related]
19. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts.
Wu JB; Fong YC; Tsai HY; Chen YF; Tsuzuki M; Tang CH
Eur J Pharmacol; 2008 Jul; 588(2-3):333-41. PubMed ID: 18495116
[TBL] [Abstract][Full Text] [Related]
20. Pitavastatin inactivates NF-kappaB and decreases IL-6 production through Rho kinase pathway in MCF-7 cells.
Wang J; Kitajima I
Oncol Rep; 2007 May; 17(5):1149-54. PubMed ID: 17390058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
